Semaglutide isn’t just “like” Ozempic. It is Ozempic. Semaglutide is the active ingredient inside every Ozempic pen. The relationship is the same as ibuprofen to Advil: one is the drug, the other is the brand name a pharmaceutical company put on the box. But the story doesn’t end there, because semaglutide is also sold under other brand names at different doses and for different purposes, and understanding those differences matters if you’re comparing options.
How Semaglutide and Ozempic Are Related
Semaglutide is a molecule that mimics a natural gut hormone called GLP-1. Your body releases GLP-1 after you eat, and it does several things at once: it triggers insulin release from your pancreas, blocks a hormone that raises blood sugar, slows down how fast your stomach empties, and signals your brain that you’re full. Semaglutide copies all of these effects, but it lasts much longer in your body than natural GLP-1, which breaks down within minutes.
Ozempic is one specific product built around that molecule. It’s a prefilled injection pen, administered once a week under the skin, and it’s FDA-approved for type 2 diabetes. The FDA label reads simply: “OZEMPIC (semaglutide) injection, for subcutaneous use.” So when people talk about semaglutide and Ozempic, they’re talking about the same drug in one particular package.
Three Brand Names, One Drug
Novo Nordisk, the company that developed semaglutide, sells it under three brand names. Each targets a different condition and comes in a different form or dose.
- Ozempic is an injectable pen approved for type 2 diabetes. It starts at 0.25 mg per week and tops out at 2 mg per week. In clinical trials, it lowered A1c (a measure of long-term blood sugar) by 0.6 to 1.6 percentage points compared to other treatments.
- Wegovy is also an injectable pen, but it’s approved for weight management and cardiovascular risk reduction. Its maximum dose is 2.4 mg per week, slightly higher than Ozempic’s ceiling. In trials testing the newest high dose (7.2 mg), participants lost an average of 18.7% of their body weight, though the standard 2.4 mg dose produced around 15.6% loss. Wegovy is also approved for weight management in adolescents aged 12 and older, and it recently gained approval for a form of fatty liver disease called MASH.
- Rybelsus is a daily oral tablet, not an injection. It’s approved for type 2 diabetes and maxes out at 14 mg per day. You take it on an empty stomach with no more than 4 ounces of water, then wait 30 minutes before eating or drinking anything else.
You should not combine any of these products. The Wegovy label states explicitly that it should not be used alongside other semaglutide-containing products or any other GLP-1 medication.
Why the Dose Difference Matters
Ozempic and Wegovy contain the exact same molecule in the exact same type of injection pen, but the dosing targets are different. Ozempic’s maintenance range is 0.5 mg to 2 mg per week, calibrated for blood sugar control. Wegovy ramps up to 2.4 mg per week (and in newer trials, 7.2 mg), calibrated for weight loss and cardiovascular protection. That higher ceiling is why Wegovy tends to produce more weight loss than Ozempic when each is used at its approved dose.
This distinction is partly why doctors prescribe one over the other. If your primary issue is type 2 diabetes, Ozempic is the standard choice. If you’re focused on weight loss or have heart disease risk alongside obesity, Wegovy fits the approved indication. In practice, many people on Ozempic for diabetes also lose weight, which is one reason the drug became so well known for that effect, but the formal approval for weight management belongs to Wegovy.
What Side Effects to Expect
Because all three brands contain semaglutide, they share the same side effect profile. The most common issues are gastrointestinal: nausea, vomiting, diarrhea, constipation, stomach pain, bloating, gas, and heartburn. These tend to be worst during the dose-escalation phase, when your body is adjusting to each increase, and they often ease over several weeks.
The slow ramp-up schedule exists specifically to reduce these effects. Ozempic, for example, starts at 0.25 mg for four weeks before increasing to 0.5 mg. Wegovy follows a similar gradual escalation over months before reaching the full 2.4 mg dose.
Compounded Semaglutide Is Not the Same
If you’ve seen semaglutide offered at a lower price from a compounding pharmacy or online clinic, that product is not equivalent to Ozempic or Wegovy. Compounded semaglutide does not undergo FDA review for safety, quality, or effectiveness. The FDA has received reports of hospitalizations tied to dosing errors with compounded versions, including severe nausea, vomiting, fainting, dehydration, acute pancreatitis, and gallstones.
The problems stem from inconsistency. Compounded products come in varying concentrations, and instructions sometimes list doses in “units” rather than milligrams, which can lead to accidental overdoses. Some compounders also use salt forms of semaglutide (like semaglutide sodium or semaglutide acetate) rather than the base form used in approved products. The FDA has stated it is not aware of any legal basis for compounding with these salt forms. Others mix in additional ingredients like vitamin B-12, L-carnitine, or NAD, none of which have been tested in combination with semaglutide for safety or effectiveness.
Storage and Practical Differences
Both Ozempic and Wegovy pens need refrigeration (36°F to 46°F) before first use. Once you start using an Ozempic pen, it can stay at room temperature (up to 86°F) for 56 days. Wegovy is a bit more restrictive: an unused pen can be kept at room temperature for up to 28 days, but only before the cap is removed. Neither product should be frozen, and both should be kept away from direct sunlight and excessive heat.
Rybelsus, being a tablet, doesn’t require refrigeration but does require that specific empty-stomach routine each morning. For people who strongly prefer not to inject, it’s the only oral option, though its maximum dose is lower relative to the injectable versions, and it’s only approved for diabetes, not weight loss.
Choosing Between Brand Names
Your insurance coverage often drives the decision as much as the medical indication does. Ozempic tends to be covered under diabetes benefits, while Wegovy falls under weight management, which many plans cover differently or not at all. Some people end up on Ozempic “off-label” for weight loss because their insurance won’t cover Wegovy, though the approved dose ceiling is lower.
The core takeaway is simple: semaglutide is the drug, and Ozempic is one of three branded products that deliver it. They are not just similar. They are the same molecule. The differences come down to dose, approved use, and how you take it.